IFNG and cancer: Such mutations blocked IFNγ signaling, resulting in insensitivity to its antiproliferative effects on cancer cells.85 These altered signaling pathways play a critical role in maintaining an immunosuppressive microenvironment, presenting a major obstacle for cancer immunotherapy.